Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk | Zendy

W.H. Wilson Tang | Zendy; Yuping Wu | Zendy; Jaana Hartiala | Zendy; Yiying Fan | Zendy; Alexandre F.R. Stewart | Zendy; Robert Roberts | Zendy; Ruth McPherson | Zendy; Paul L. Fox | Zendy; Hooman Allayee | Zendy; Stanley L. Hazen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk

Author(s) -

W.H. Wilson Tang,

Yuping Wu,

Jaana Hartiala,

Yiying Fan,

Alexandre F.R. Stewart,

Robert Roberts,

Ruth McPherson,

Paul L. Fox,

Hooman Allayee,

Stanley L. Hazen

Publication year - 2011

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.111.237040

Subject(s) - mace , medicine , hazard ratio , myocardial infarction , diabetes mellitus , single nucleotide polymorphism , confidence interval , cardiology , gastroenterology , endocrinology , percutaneous coronary intervention , genotype , biology , genetics , gene

Ceruloplasmin (Cp) is an acute-phase reactant that is increased in inflammatory diseases and in acute coronary syndromes. Cp has recently been shown to possess nitric oxide (NO) oxidase catalytic activity, but its impact on long-term cardiovascular outcomes in stable cardiac patients has not been explored.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research